Francisco Javier J. Gomez

Head technician
Division and Central Laboratory of Hematology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
Lausanne, Vaud, Switzerland

Presentation(s):

• PB0150 - Fibrin clot formation is a reliable biological marker to evaluate FVIII replacement therapy in hemophilia A patients.

  Sunday, June 25, 2023
  18:30 – 19:30 ET